The Valens Company (TSX:VLNS)
- Ticker 2:OTCQX:VLNCF
- CEO:Tyler Robson
The Valens Company (TSX:VLNS) Stock Price
Disclaimer: Past performance is not an indicator of future performance.
The Valens Company (TSX:VLNS) Company Overview
The Valens Company (TSX:VLNS) is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products.
Working with renowned LPs to extract and test the world's finest cannabis, Valens utilises science, art and exploration to develop new products and advanced formulations to shape the future of the industry.
Using Sub/Supercritical CO2, Ethanol, Hydrocarbon, Solvent-less and Terpenes extraction methods, Valens is a trusted partner for best-in-class extraction.
Operating a leading-edge research and analysis facility, named the "Centre of Excellence in Plant-Based Science" by Thermo Fisher Scientific, Valens is the first in Canada to be ISO 17025 accredited – the global gold standard for cannabis testing.
Partnering with Resonance Consultancy to release the first forward-looking cannabis research study since legalisation, Valens has its eyes clearly set on the future of cannabis in Canada.
With gross profits increasing to $6.3 million, or 35.8% of revenue, for the three months ended May 31, 2020, compared to $5.1 million, or 57.9% of revenue in the same period in fiscal 2019, Valens remains focused on demonstrating the value of its platform as it integrates into the supply chain of leading companies looking to bring customized, innovative products to Canadian consumers.
Health Canada also recently granted Valens a license to conduct research involving the administration or distribution of cannabis to human subjects for the assessment of taste, sight, smell or touch.
The Company will use this license to conduct controlled human trials for the sensory evaluation of its cannabis extracts, concentrates and oils, including vaporizers, and beverage and edible products, at its extraction, manufacturing and testing facilities in Kelowna, B.C.